Uterine fibroids: NICE recommends new treatment option for moderate to severe symptoms

Uterine fibroids: NICE recommends new treatment option for moderate to severe symptoms


The National Institute for Health and Care Excellence has recommended linzagolix (marketed as Yselty) for moderate to severe symptoms of uterine fibroids, an option that could benefit up to 30 000 adults in England and Wales.1

In final guidance, published on 14 August, NICE said that linzagolix can be offered …



Source link

Please follow and like us:
Pin Share

Leave a Reply

Your email address will not be published. Required fields are marked *

RSS
Follow by Email
YouTube
Pinterest
LinkedIn
Share
Telegram
Wechat
URL has been copied successfully!